Use of Iron Therapy in Chronic Kidney Disease
<p>Anemia is a common complication in patients with chronic kidney disease (CKD), and increases with the progression of renal dysfunction [1]. The main cause of anemia is the inadequate production of erythropoietin (EPO), a glycoprotein mainly produced by the kidney responsible for the growth...
Saved in:
Main Authors: | Jacques Rottembourg (Author), Guy Rostoker (Author) |
---|---|
Format: | Book |
Published: |
Archives of Clinical Nephrology - Peertechz Publications,
2016-01-06.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stage V Chronic Kidney Disease: A plea for Home Dialysis
by: Belkacem Issad, et al.
Published: (2022) -
A dialysis doctor's memories with COVID-19 disease
by: Guy Rostoker
Published: (2021) -
Iron Status and Inflammation in Early Stages of Chronic Kidney Disease
by: Ewelina Łukaszyk, et al.
Published: (2015) -
Differential Pharmacokinetics of Liver Tropism for Iron Sucrose, Ferric Carboxymaltose, and Iron Isomaltoside: A Clue to Their Safety for Dialysis Patients
by: Guy Rostoker, et al.
Published: (2022) -
Hemodialysis Duration with Levels of Hemoglobin, Hematocrit, Serum Iron and Total Iron Binding Capacity on Chronic Kidney Disease
by: Supriati Wila Djami, et al.
Published: (2021)